Serosurveys and convalescent plasma in COVID-19.
作者信息
Pérez-Cameo Cristina, Marín-Lahoz Juan
机构信息
Emergency Department; Hospital Universitari Vall d'Hebron; Passeig de la Vall d'Hebron 119-129; 08035 Barcelona (SPAIN).
Neurology Department and Emergency Department; Hospital de la Santa Creu I Sant Pau; C/ Mas Casanovas 90; 08041 Barcelona (SPAIN).
出版信息
EClinicalMedicine. 2020 May 1;23:100370. doi: 10.1016/j.eclinm.2020.100370. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
Serosurveys and convalescent plasma in COVID-19.新型冠状病毒肺炎的血清学调查与恢复期血浆
EClinicalMedicine. 2020 May 1;23:100370. doi: 10.1016/j.eclinm.2020.100370. eCollection 2020 Jun.
2
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
3
Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study.恢复期血浆输注治疗新型冠状病毒肺炎——来自波兰的经验：一项多中心研究
J Clin Med. 2020 Dec 24;10(1):28. doi: 10.3390/jcm10010028.
4
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
5
Effects and Safety of Convalescent Plasma Administration in a Group of Polish Pediatric Patients with COVID-19: A Case Series.一组波兰新冠病毒肺炎儿科患者接受恢复期血浆治疗的疗效与安全性：病例系列报告
Life (Basel). 2021 Mar 17;11(3):247. doi: 10.3390/life11030247.
6
Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia.恢复期血浆疗法联合瑞德西韦成功挽救了一名患有重症COVID-19肺炎的早期肝移植受者。
Ann Hepatobiliary Pancreat Surg. 2020 Nov 30;24(4):526-532. doi: 10.14701/ahbps.2020.24.4.526.
7
Convalescent Plasma: Education and Administration Implications.恢复期血浆：教育和管理影响。
Clin J Oncol Nurs. 2021 Feb 1;25(1):28-32. doi: 10.1188/21.CJON.28-32.
引用本文的文献
1
A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2.一种多功能中和抗体偶联纳米颗粒抑制和失活 SARS-CoV-2。
Adv Sci (Weinh). 2022 Jan;9(2):e2103240. doi: 10.1002/advs.202103240. Epub 2021 Nov 10.
2
Nanotraps for the containment and clearance of SARS-CoV-2.用于遏制和清除新型冠状病毒的纳米陷阱。
Matter. 2021 Jun 2;4(6):2059-2082. doi: 10.1016/j.matt.2021.04.005. Epub 2021 Apr 22.
3
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
4
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.用于治疗新型冠状病毒肺炎的恢复期血浆疗法：当前全球大流行中的观点与应用
Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728. doi: 10.2147/RMHP.S281388. eCollection 2020.
5
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.新型冠状病毒病 2019（COVID-19）：免疫病理学、血清学诊断和治疗概述。
Scand J Immunol. 2021 Apr;93(4):e12998. doi: 10.1111/sji.12998. Epub 2020 Dec 3.
本文引用的文献
1
Spread of SARS-CoV-2 in the Icelandic Population.SARS-CoV-2 在冰岛人群中的传播。
N Engl J Med. 2020 Jun 11;382(24):2302-2315. doi: 10.1056/NEJMoa2006100. Epub 2020 Apr 14.
2
Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village.新冠疫情：识别并隔离无症状感染者助力意大利村庄消灭病毒。
BMJ. 2020 Mar 23;368:m1165. doi: 10.1136/bmj.m1165.
3
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).新型冠状病毒感染（COVID-19）无症状感染率的估计。
Int J Infect Dis. 2020 May;94:154-155. doi: 10.1016/j.ijid.2020.03.020. Epub 2020 Mar 14.
4
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
5
Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo.刚果民主共和国医护人员中埃博拉病毒血清标志物。
J Infect Dis. 2019 Jan 29;219(4):517-525. doi: 10.1093/infdis/jiy499.
6
Hark back: passive immunotherapy for influenza and other serious infections.追溯：流感和其他严重感染的被动免疫疗法。
Crit Care Med. 2010 Apr;38(4 Suppl):e66-73. doi: 10.1097/CCM.0b013e3181d44c1e.
7
Anti-SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China.中国广州医护人员体内的抗严重急性呼吸综合征冠状病毒免疫球蛋白G
Emerg Infect Dis. 2005 Jan;11(1):89-94. doi: 10.3201/eid1101.040138.
Zotero 插件